Search results
Author(s):
Ilias Kanellos
Added:
4 years ago
Dr Ilias Kanellos (Ahepa University Hospital, Thessaloniki, GR) discusses theimpact of combined multimodal approach in rehospitalisation and morbidity rate of HF patients.
Filmed on site at HFA 2019 by Radcliffe Cardiology.
Videography: Mike Knight & Tom Green
Interviewer: Liam O'Niell
View more
Author(s):
Attilio Iacovoni
,
Emilia D’Elia
,
Mauro Gori
,
et al
Added:
3 years ago
Heart failure (HF) is a pandemic, chronic degenerative disease estimated to affect 38 million people worldwide, a number expected to increase with the ageing of the population.1 As a syndrome, it is associated with high mortality and morbidity, and consistently requires increasing resources. HF is the most frequent cause of hospitalisation in patients aged over 65 years, and hospitalised patients…
View more
Author(s):
Michela Faggioni
,
Domenico G Della Rocca
,
Sanghamitra Mohanty
,
et al
Added:
3 years ago
Heart failure with reduced ejection fraction (HFrEF) and AF share several predisposing risk factors and often coexist in the same population.1 Although AF can be a marker of worsening heart failure (HF), it can also be a main driver of disease progression. The presence of AF in patients with HFrEF is associated with an increased risk of stroke, re-hospitalisations and all-cause death.2 Therefore,…
View more
Author(s):
Ingibjörg Kristjánsdóttir
,
Tonje Thorvaldsen
,
Lars H Lund
Added:
3 years ago
From Acute Heart Failure Towards Worsening or De Novo Heart Failure
The natural history of heart failure (HF) is characterised by disease progression and episodes of worsening HF and acute decompensation requiring outpatient treatment intensification, emergency department or in-hospital care.
Acute HF (AHF), also known as acute decompensated HF, is defined as a progressive and sometimes rapid…
View more
Author(s):
Jozine ter Maaten
Added:
7 months ago
ESC 2023 — Dr Jozine Ter Maaten (University Medical Centre Groningen, NL) joins us to outline the findings from the PUSH-AHF Study (NCT04606927).
PUSH-AHF (University Medical Center Groningen) aimed to assess the effect of natriuresis-guided therapy in patients with acute heart failure to improve diagnostic response, decongestion and clinical outcomes. 310 patients with a primary diagnosis of…
View more
Author(s):
Eilidh Hill
,
Jackie Taylor
Added:
3 years ago
In developed countries, it is estimated that 1–2 % of the adult population has heart failure (HF), with the prevalence increasing to more than 10 % in those aged >70 years.1 Despite advances in therapies for heart failure with reduced ejection fraction (HFrEF), it remains a condition associated with significant morbidity and mortality, punctuated by episodes of unplanned hospitalisation.2
HF…
View more
Author(s):
Nicholas Wettersten
,
Alan S Maisel
Added:
3 years ago
Cardiac troponin (cTn) is the core biomarker for the diagnosis of a myocardial infarct (MI).1 Indeed, as stated in Table 1, it meets all the definitions of a biomarker for acute coronary syndrome (ACS), as suggested by Maisel.2 In the setting of ACS, in addition to its diagnostic use, it is prognostic, clinically actionable and can be monitored during therapy as a surrogate of improvement. In…
View more
Foreword
Author(s):
Andrew JS Coats
,
Giuseppe Rosano
Added:
3 years ago
Article
Author(s):
Amam Mbakwem
,
Francis Aina
,
Casmir Amadi
Added:
3 years ago
The prevalence of major depression in chronic heart failure (HF) is about 20–40 %, which is 4–5 % higher than in the normal population.1–3 Depression in heart failure has become a major issue as the burden of heart failure has continued to increase, and many studies have suggested poorer outcomes in HF patients reporting depression.4–8 The cost of managing HF has continued to escalate, and high…
View more
Author(s):
Ivan Milinkovic
,
Giuseppe Rosano
,
Yury Lopatin
,
et al
Added:
3 years ago
Chronic heart failure (HF), a complex and heterogeneous clinical syndrome, is a major cause of morbidity and mortality worldwide, and represents a major challenge to health care systems. The prevalence of HF and the number of hospitalisations is rising, even more in the ageing population.1 The direct costs of HF management reached 1–2 % of total health care expenditure and approximately two…
View more